Listed

ICU Medical Inc: Form 10-Q for the period ended Jun 30, 2010

Filed with the SEC on Jul 23, 2010 and accepted by EDGAR at Jul 23, 2010, 12:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2010-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2010-04-01 to 2010-06-30$68.9mus-gaap:Revenues
Revenue6 months2010-01-01 to 2010-06-30$133.2mus-gaap:Revenues
Cost of revenue3 months2010-04-01 to 2010-06-30$36.7mus-gaap:CostOfGoodsSold
Cost of revenue6 months2010-01-01 to 2010-06-30$74.2mus-gaap:CostOfGoodsSold
Gross profit3 months2010-04-01 to 2010-06-30$32.1mus-gaap:GrossProfit
Gross profit6 months2010-01-01 to 2010-06-30$59.1mus-gaap:GrossProfit
Research and development3 months2010-04-01 to 2010-06-30$952.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2010-01-01 to 2010-06-30$1.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2010-04-01 to 2010-06-30$19.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2010-01-01 to 2010-06-30$39.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2010-04-01 to 2010-06-30$11.8mus-gaap:OperatingIncomeLoss
Operating income6 months2010-01-01 to 2010-06-30$18.2mus-gaap:OperatingIncomeLoss
Income tax3 months2010-04-01 to 2010-06-30$4.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2010-01-01 to 2010-06-30$6.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2010-04-01 to 2010-06-30$7.7mus-gaap:ProfitLoss
Net income6 months2010-01-01 to 2010-06-30$12.0mus-gaap:ProfitLoss
Diluted EPS3 months2010-04-01 to 2010-06-30$0.56us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2010-01-01 to 2010-06-30$0.86us-gaap:EarningsPerShareDiluted
Basic EPS3 months2010-04-01 to 2010-06-30$0.57us-gaap:EarningsPerShareBasic
Basic EPS6 months2010-01-01 to 2010-06-30$0.88us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2010-04-01 to 2010-06-3013,657,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2010-01-01 to 2010-06-3013,888,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2010-01-01 to 2010-06-30$17.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2010-01-01 to 2010-06-30$11.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2010-01-01 to 2010-06-30$28.6mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2010-06-30$57.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2010-06-30$184.3mus-gaap:AssetsCurrent
Total assetsAt period end2010-06-30$286.7mus-gaap:Assets
Current liabilitiesAt period end2010-06-30$31.3mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2010-06-30$244.9mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001104659-10-039265. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.